Virtual reality as pain management is taking off

VR is quickly becoming a new alternative to more traditional methods of pain management, NPR reported, with patients escaping their chronic pain by strapping on a VR headset and becoming immersed in a different reality.

The experience, which helps the brain take focus off pain temporarily, could help reduce the dependence on pain pills.

For some patients, the relaxing effects of a VR simulation, such as swimming with dolphins or walking through a forest, can last for days. Recent studies also support that VR can change the way patients perceive pain, and the explanations why vary.

But many agree that engaging the mind keeps other stimuli, like pain, out.

“In other words, when something captures our attention and uses all our senses, we focus on it,” NPR reporter. “It's like a spotlight—and everything else falls into darkness—at least temporarily.”

The findings come at a time when the opioid abuse epidemic claimed 68,000 lives in 2018.

See the full story below:

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.